Wobble Genomics to present novel mRNA sequencing research at AACR 2026 (opens in new tab)
Wobble Genomics will present new data at the AACR Annual Meeting 2026, highlighting its approach to sequencing full-length mRNA from blood to support antibody-drug conjugate (ADC) therapy selection in breast cancer. Poster: Sequencing Full-Length mRNA in Whole Blood of Breast Cancer Patients for ADC Therapy SelectionSession: Liquid Biopsies: Circulating Nucleic Acids 3Date: April 20, 2026 | 2:00–5:00 PMLocation: Poster ...
Read the original article